Scholars Central

EditorialPublished 26 Apr 2021

Recombinant SARS-CoV-2 receptor-binding domain.

Authors: Rosari MoralesEspinosa

Hematology and Blood Disorders

Volume 4 · Issue 2 · Pages 51

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

SARS-CoV-2 is a RNA beta coronavirus that has a place with the family Coronaviridae. Other infections of the very family that can taint human populaces are the Middle East Respiratory Syndrome (MERS) and SARS-CoV. This infection taints the host cells through its spike (S) glycoprotein, which has become the practical objective in antibody advancement. Researchers have built up a falsely planned S trimer, mirroring the local S trimer structure. In the development of a counterfeit S trimer, the C-terminal locale of human sort Iα collagen has been consolidated and viably utilized in antibody research. The CoV spike (S) protein assumes the main parts in viral connection, combination and section, and fills in as an objective for advancement of antibodies, passage inhibitors and immunizations.

Subjects

Haematology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Hematology and Blood Disorders.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalHematology and Blood Disorders
  • SubjectHaematology
  • BylineArticles whose byline prints “Rosari MoralesEspinosa”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels